Comparison of population and 454 "deep" sequence analysis for HIV type 1 tropism versus the original trofile assay in non-B subtypes

AIDS Research and Human Retroviruses

Volumn 29, Issue 6, 2013, Pages 979-984

  Lee, Guinevere Q ^a,b   Harrigan, P Richard ^a,b   Dong, Winnie ^a   Poon, Art F Y ^a   Heera, Jayvant ^c   Demarest, James ^d   Rinehart, Alex ^d   Chapman, Doug ^e   Valdez, Hernan ^e   Portsmouth, Simon ^e  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d VIIV HEALTHCARE   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GENETIC ALGORITHM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INTERMETHOD COMPARISON; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRAL TROPISM; VIRUS RECOMBINANT; VIRUS STRAIN;

ALGORITHMS; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV-1; PEPTIDE FRAGMENTS; PHENOTYPE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; VIRAL TROPISM;

EID: 84877857446     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0338     Document Type: Article

References (20)

1. Griffin S: Viral replication. In: Human Immunodeficiency Virus (Richman DD, ed.). International Medical Press, London, 2003, pp. 313-315
2. Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, Macartney M, et al.: Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother 2005;49(11):4721-4732
3. Fätkenheuer G, Pozniak AL, Johnson MA, Plettenberg A, Staszewski S, Hoepelman AIM, et al.: Efficacy of short-Term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nature Med 2005;11(11):1170-1172
4. Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AIM, Lampiris H, et al.: Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N Engl J Med 2008;359(14):1442-1455
5. Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, et al.: Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med 2008;359(14):1429-1441
6. Sing T, Low AJ, Beerenwinkel N, Sander O, Cheung PK, Domingues FS, et al.: Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther 2007; 12(7):1097-1106
7. Jensen MA, Li FS, van't Wout AB, Nickle DC, Shriner D, He HX, et al.: Improved coreceptor usage prediction and genotypic monitoring of R5-To-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 2003;77(24):13376-13388
8. McGovern R, Dong W, Zhong X, Knapp D, Thielen A, Chapman D, et al.: Population-based sequencing of the V3-loop is comparable to the enhanced sensitivity Trofile Assay in predicting virologic response to maraviroc of treatmentnai ?ve patients in the MERIT Trial. In: 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2010
9. Jensen MA, Coetzer M, van't Wout AB, Morris L, and Mullins JI: A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol 2006;80(10):4698-4704
10. Napolitano L, Tressler T, Coakley E, Santos C, Heera J, and Whitcomb J: Incorporation of optimized primers into the Trofile assay substantially improves determination of viral tropism in genetically diverse HIV subtypes. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, Sept ember12-15, 2009
11. McGovern RA, Thielen A, Mo T, Dong W, Woods CK, Chapman D, et al.: Population-based V3 genotypic tropism assay: A retrospective analysis using screening samples from the A4001029 and MOTIVATE studies. AIDS 2010;24(16): 2517-2525
12. Swenson LC, McGovern RA, Dong W, Mo T, Lee GQ, Woods C, et al.: Optimization of clinically relevant cutoffs for determining HIV co-receptor use by population and ''deep'' sequencing methods. In: 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009
13. McGovern RA, Dong W, Mo T, Woods C, Zhong X, Thielen A, et al.: Optimization of clinically relevant cutpoints for the determination of HIV co-receptor usage to predict maraviroc responses in treatment experienced (TE) patients using population V3 genotyping. In: 12th European AIDS Conference, Cologne, Germany, 2009
14. McGovern RA, Thielen A, Portsmouth S, Mo T, Dong W, Woods CK, et al.: Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial. J Acquir Immune Defic Syndr 2012;61(3):279-286
15. Swenson LC, Dong W, Mo T, Woods C, Zhong X, Thielen A, et al.: ''Deep'' sequencing to identify treatment-experienced patients who respond to maraviroc (MVC) . In: 12th European AIDS Conference, Cologne, Germany, 2009
16. Swenson LC, Mo T, Dong WWY, Zhong X, Woods CK, Jensen Ma, et al.: Deep sequencing to infer HIV-1 co-receptor usage: Application to three clinical trials of maraviroc in treatment-experienced patients. J Infect Dis 2011;203(2): 237-245
17. Swenson LC, Mo T, Dong WWY, Zhong X, Woods CK, Thielen A, et al.: Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: A reanalysis of the MERIT trial of maraviroc. Clin Infect Dis 2011;53(7):732-742
18. Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, et al.: Coreceptor tropism in human immunodeficiency virus type 1 subtype D: High prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 2007;81(15):7885-7893
19. Raymond S, Delobel P, Mavigner M, Ferradini L, Cazabat M, Souyris C, et al.: Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses. J Acquir Immune Defic Syndr 2010;53(2):167-175
20. Raymond S, Delobel P, Chaix ML, Cazabat M, Encinas S, Bruel P, et al.: Genotypic prediction of HIV-1 subtype D tropism. Retrovirology 2011;8:56